About EMESO
EMESO is a company based in London (United Kingdom) founded in 2023. It operates as a SaaS and B2B. EMESO offers products and services including Acut e-CD and EMESO Platform. EMESO operates in a competitive market with competitors including Sable Bio, Intero Biosystems, Pharmacovigilance, Mensura Health and Metsystem, among others.
- Headquarter London, United Kingdom
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Emeso Ltd.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of EMESO
EMESO offers a comprehensive portfolio of products and services, including Acut e-CD and EMESO Platform.
API-driven electronic register to manage controlled drugs and save clinician time.
Digital tool for improving clinical efficiency and safety in healthcare settings.
Funding Insights of EMESO
Detailed funding history for EMESO
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by EMESO
Investment portfolio details for EMESO
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - EMESO
Detailed financials for EMESO
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Emeso Comparisons
Peer comparison for EMESO
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of EMESO
EMESO operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sable Bio, Intero Biosystems, Pharmacovigilance, Mensura Health and Metsystem, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Drug safety risks are predicted via AI in pharmaceuticals.
|
|
| Locked | Locked | Locked |
Develops human organoids for preclinical drug testing and research applications.
|
|
| Locked | Locked | Locked |
Delivers data analytics dashboards for drug safety professionals.
|
|
| Locked | Locked | Locked |
Mensura Health is focused on epilepsy patient management solutions.
|
|
| Locked | Locked | Locked |
Offers advanced drug screens for predicting cancer metastasis and personalized treatments.
|
|
| Locked | Locked | Locked |
Develops software for virtual patient modeling, clinical trial simulations, and drug response prediction.
|
Detailed competitors of EMESO
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Emeso
Complete news archive for EMESO
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about EMESO
EMESO was founded in 2023.
EMESO is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
EMESO is a digital platform aimed at improving medicines safety and clinical efficiency by replacing traditional manual processes in healthcare. It offers API-driven tools like Acut e-CD, an electronic Controlled Drug register, which integrates with existing systems to save time and enhance incident management. Based in London, United Kingdom, it empowers nursing and pharmacy teams, particularly in organizations like the NHS, through seamless cloud-based solutions.
EMESO's top competitors include Sable Bio, Intero Biosystems and Pharmacovigilance.
EMESO offers Acut e-CD and EMESO Platform.